Dorothee Nickles

11.9k total citations
26 papers, 895 citations indexed

About

Dorothee Nickles is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Dorothee Nickles has authored 26 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Immunology and 7 papers in Surgery. Recurrent topics in Dorothee Nickles's work include Cancer Immunotherapy and Biomarkers (9 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Ferroptosis and cancer prognosis (5 papers). Dorothee Nickles is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Ferroptosis and cancer prognosis (5 papers). Dorothee Nickles collaborates with scholars based in United States, France and Germany. Dorothee Nickles's co-authors include Sergio E. Baranzini, Stephen L. Hauser, David Leppert, Sarah Jahn, Mia Derstine, Arumugam Palanichamy, H.‐Christian von Büdingen, Huizhong Xiong, Rafael Cubas and Марина Москаленко and has published in prestigious journals such as Journal of Clinical Oncology, Immunity and The Journal of Immunology.

In The Last Decade

Dorothee Nickles

24 papers receiving 879 citations

Peers

Dorothee Nickles
Mahdia Benkhoucha Switzerland
Yonghao Cao United States
Can Küçük Türkiye
Sarah Wilkinson United Kingdom
Carolyn Rainer United States
Natalia Pikor Switzerland
Sylvia K. Odesa United States
Mahdia Benkhoucha Switzerland
Dorothee Nickles
Citations per year, relative to Dorothee Nickles Dorothee Nickles (= 1×) peers Mahdia Benkhoucha

Countries citing papers authored by Dorothee Nickles

Since Specialization
Citations

This map shows the geographic impact of Dorothee Nickles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothee Nickles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothee Nickles more than expected).

Fields of papers citing papers by Dorothee Nickles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothee Nickles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothee Nickles. The network helps show where Dorothee Nickles may publish in the future.

Co-authorship network of co-authors of Dorothee Nickles

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothee Nickles. A scholar is included among the top collaborators of Dorothee Nickles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothee Nickles. Dorothee Nickles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solon, Margaret, Nianfeng Ge, Susan Haller, et al.. (2024). ZBP1 and TRIF trigger lethal necroptosis in mice lacking caspase-8 and TNFR1. Cell Death and Differentiation. 31(5). 672–682. 21 indexed citations
2.
Besla, Rickvinder, Elicia Penuel, Ely Cosino, et al.. (2023). T cell–Dependent Bispecific Therapy Enhances Innate Immune Activation and Antibody-Mediated Killing. Cancer Immunology Research. 12(1). 60–71. 6 indexed citations
3.
Xiong, Huizhong, Stephanie Mittman, Марина Москаленко, et al.. (2019). Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment. Cancer Research. 79(7). 1493–1506. 138 indexed citations
4.
Xiong, Huizhong, Stephanie Mittman, Марина Москаленко, et al.. (2019). Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models. Cancer Immunology Research. 7(6). 963–976. 31 indexed citations
5.
Long, Jason E., Matthew Wongchenko, Dorothee Nickles, et al.. (2019). Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation. Cell Death and Differentiation. 26(11). 2416–2429. 24 indexed citations
6.
Fewings, Nicole, Prudence N. Gatt, Fiona C. McKay, et al.. (2017). The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis. Journal of Autoimmunity. 78. 57–69. 23 indexed citations
7.
Mariathasan, Sanjeev, Shannon J. Turley, Dorothee Nickles, et al.. (2017). TGF-β signalling attenuates tumour response to PD-L1 checkpoint blockade by contributing to retention of T cells in the peritumoural stroma. Annals of Oncology. 28. xi30–xi30. 8 indexed citations
8.
Fewings, Nicole, Prudence N. Gatt, Fiona C. McKay, et al.. (2017). Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis. Data in Brief. 11. 364–370. 5 indexed citations
9.
Ackerman, Charlotte, Sanjeev Mariathasan, Dorothee Nickles, et al.. (2017). Molecular subtyping of metastatic urothelial bladder cancer.. Journal of Clinical Oncology. 35(6_suppl). 326–326.
10.
Powles, Thomas, Dorothee Nickles, Eliezer M. Van Allen, et al.. (2015). Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). Journal for ImmunoTherapy of Cancer. 3(S2). 11 indexed citations
11.
Palanichamy, Arumugam, Sarah Jahn, Dorothee Nickles, et al.. (2014). Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients. The Journal of Immunology. 193(2). 580–586. 215 indexed citations
12.
Parnell, Grant P., Prudence N. Gatt, Małgorzata Krupa, et al.. (2014). The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clinical Immunology. 151(1). 16–24. 44 indexed citations
13.
Khankhanian, Pouya, Sergio E. Baranzini, Britt Johnson, et al.. (2013). Sequencing of the IL6 gene in a case–control study of cerebral palsy in children. BMC Medical Genetics. 14(1). 126–126. 16 indexed citations
14.
Nickles, Dorothee, Michael Li, Pouya Khankhanian, et al.. (2013). Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls. Human Molecular Genetics. 22(20). 4194–4205. 60 indexed citations
15.
Baranzini, Sergio E. & Dorothee Nickles. (2012). Genetics of multiple sclerosis. Current Opinion in Neurology. 25(3). 239–245. 40 indexed citations
16.
Möck, Thomas, Dorothee Nickles, Michael K. Kießling, et al.. (2012). A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes. Immunity. 37(4). 697–708. 48 indexed citations
17.
Nickles, Dorothee, Lohith Madireddy, Shan Yang, et al.. (2012). In depth comparison of an individual’s DNA and its lymphoblastoid cell line using whole genome sequencing. BMC Genomics. 13(1). 477–477. 28 indexed citations
18.
Metzig, Marie Oliver, Dorothee Nickles, Christina Falschlehner, et al.. (2011). An RNAi screen identifies USP2 as a factor required for TNF‐α‐induced NF‐κB signaling. International Journal of Cancer. 129(3). 607–618. 46 indexed citations
19.
Metzig, Marie Oliver, Dorothee Nickles, & Michael Boutros. (2010). Large-Scale RNAi Screens to Dissect TNF and NF-κB Signaling Pathways. Advances in experimental medicine and biology. 691. 131–139. 2 indexed citations
20.
Nickles, Dorothee, et al.. (2008). End-stage dying glioma cells are engulfed by mouse microglia with a strain-dependent efficacy. Journal of Neuroimmunology. 197(1). 10–20. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026